Pentamidine |
Chitosan coated niosomes |
Parkinson’s disease |
Intranasal |
Rinaldi et al., 2019 |
Methotrexate |
Chitosan hydrogel nanoparticles |
Antineoplastic agent |
Intravenous |
Pourtalebi-Jahromi et al., 2019 |
Carbamazepine |
Chitosan coated lipid nanoparticle formulation |
Epilepsy |
Oral |
Ana et al., 2019 |
Rotigotine |
Chitosan nanoparticles |
Parkinson’s disease |
Intranasal |
Tzeyung et al., 2019 |
Doxorubicin/erlotinib |
Chitosan liposomal nanoparticles |
Glioblastoma |
– |
Lakkadwala and Singh, 2019 |
Docetaxel |
TMC hydrogel |
Glioblastoma |
Intracranial injection |
Turabee et al., 2019 |
Risperidone |
Chitosan lipid nanoparticle |
Schizophrenia |
Intranasal |
Qureshi et al., 2019 |
Pramipexole dihydrochloride |
Chitosan nanoparticles |
Parkinson’s Disease |
Intranasal |
Raj et al., 2018 |
Galantamine |
Chitosan nanoparticles |
Amnesia/Alzheimer |
Intranasal |
Sunena et al., 2019 |
Selegiline |
Chitosan nanoparticles |
Parkinson Disease |
Intranasal |
Sridhar et al., 2018 |
Temozolomide |
Nano lipid chitosan hydrogel |
Antineoplastic agent |
Intranasal |
Khan et al., 2018 |
Cyclovirobuxine d |
Chitosan nanoparticles |
Cerebrovascular disease |
Intranasal |
Wei et al., 2018 |
Diazepam |
Chitosan mucoadhesive microemulsion |
Status epilepticus |
Intranasal |
Ramreddy and Janapareddi, 2019 |
Tapentadol hydrochloride |
Chitosan nanoparticles |
Pain |
Intranasal |
Javia and Thakkar, 2017 |
Rivastigmine hydrogen tartrate |
Chitosan mucoadhesive microemulsion |
Cholinesterase inhibitor |
Intranasal |
Shah et al., 2018 |
Ribavirin |
Chitosan microparticle agglomerates |
Viral infection |
Intranasal |
Giuliani et al., 2018 |
Huperzine A |
Lactoferrin-conjugated TMC surface-modified PLGA nanoparticles |
Alzheimer’s disease |
Intranasal |
Meng et al., 2018 |
Ropinirolle-detran sulfate |
Chitosan mucoadhesive neuro-nanoemulsion |
Parkinson’s disease |
Intranasal |
Pardeshi and Belgamwar, 2018 |
Zolmitriptan |
Chitosan mucoadhesive nanoemulsion |
Migraine |
Intranasal |
Abdou et al., 2017 |
Desvenlafaxine |
PLGA-chitosan nanoparticles |
Depression |
Intranasal |
Tong et al., 2017 |
Selegiline hydrochloride |
Thiolated chitosan nanoparticles |
Depression |
Intranasal |
Singh et al., 2016 |
Quetiapine fumarate |
Chitosan microemulsion |
Schizophrenia |
Intranasal |
Shah et al., 2016 |
Rasagiline |
Chitosan glutamate nanoparticles |
Parkinson’s disease |
Intranasal |
Mittal et al., 2016 |
Ropinirole hydrochloride |
Chitosan mucoadhesive nanoparticles |
Parkinson’s disease |
Intranasal |
Jafarieh et al., 2015 |
Buspirone hydrochloride |
Thiolated chitosan nanoparticles |
General anxiety disorder |
Intranasal |
Bari et al., 2015 |
Doxepin hydrochloride |
Chitosan-glycerophosphate-PEG thermoreversible biogels |
Depression |
Intranasal |
Naik and Nair, 2014 |
Buspirone |
Chitosan mucoadhesive microemulsion |
General anxiety disorder |
Intranasal |
Bshara et al., 2014 |
Donepezil |
Chitosan nanosuspension |
Alzheimer disease |
Intranasal |
Bhavna et al., 2014 |
Levodopa |
Chitosan nanoparticles |
Parkinson’s Disease |
Intranasal |
Sharma et al., 2014 |